Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yushuda Tablet for Mild to Moderate Depression (Phase III, China)
CTR20222691Phase 3Completed
- Sponsor
- Sinopharm Tongjitang Pharmaceutical
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Yushuda in major depressive disorder (MDD), sponsored by Sinopharm Tongjitang Pharmaceutical. Started Oct 2022; status: completed.
02
Drugs
Yushuda
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20222691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222691.